StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.75+0.04 (+5.86%)

Close on Nov 17, 2026Market cap $48.11MP/E –Yield –

iBio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

iBio's total debt was $643.00K at Dec 31, 2024. For fiscal 2024 it was $766.00K.

Annual total debt

PeriodPeriod endValueChange
FY2024Jun 30, 2024$766.00K–
FY2021Jun 30, 2021$0-100.0%
FY2020Jun 30, 2020$339.00K–
FY2019Jun 30, 2019$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2025CQ4 2024Dec 31, 2024$643.00K-97.1%
Q1 FY2025CQ3 2024Sep 30, 2024$706.00K–
Q4 FY2024CQ2 2024Jun 30, 2024$766.00K+2152.9%
Q3 FY2022CQ1 2022Mar 31, 2022$22.12M+16285.2%
Q2 FY2022CQ4 2021Dec 31, 2021$22.05M+9166.0%
Q4 FY2021CQ2 2021Jun 30, 2021$0-100.0%
Q3 FY2021CQ1 2021Mar 31, 2021$34.00K–
Q2 FY2021CQ4 2020Dec 31, 2020$135.00K–
Q1 FY2021CQ3 2020Sep 30, 2020$238.00K–
Q4 FY2020CQ2 2020Jun 30, 2020$339.00K–
Q4 FY2019CQ2 2019Jun 30, 2019$0–

More iBio figures

See a number that looks wrong?